Crafting vaccine adjuvant formulations for farmed animals demands specialized expertise and experience. Leveraging our 100 years of combined proficiency in adjuvant formulation, we have successfully developed a comprehensive suite of adjuvants known as ICTYOLANE.
Our Proprietary Adjuvant Technologies

Water in oil (W/O) emulsion
Ellicacy

Microemulsion
New technology

Polymer dispersion
Polymeric adjuvant

Water in oil in water
(W/O/W)
Dual properties

Oil in water (0/W) emulsion
Flexible and safe
Animal Species Covered
The science behind our adjuvants:
Our commercial Ictyolane adjuvants are developed from bench to market after a selection for their immunological properties based on R&D in a murine model and in the target animal specie(s). By design, we constantly improve our knowledge on structure-to-function relationships to optimize the adjuvant’s efficacy and safety. We perform in-depth immunological mechanisms of action studies on each of our Ictyolane adjuvants by using best in class, modern analysis techniques such as ELISA, ELISPOT, FLUOROSPOT or FLOW CYTOMETRY.
Our preferred innovative themes
Revolutionizing galenic design through the introduction of new products and applications, and continually pushing the frontiers of innovation.
- Adjuvant Technological Platform
- Sustainable
- Cost Efficient
- Faster Elimination at the Injection Site
- Less Vaccine Remnants
- Less Antigens to be Injected
- Less Doses to be Injected
- Innovative Vaccination Routes : Oral – Spray – Mucosal – In-Ovo – Immersion
EXCiPACT® and ISO 9001 certified
Equipment qualification/calibration, process scaling up, process validation, stability studies, QC and QA : all parameters are comprehensively addressed to guarantee industrial reproducibility and repeatability. We put a particular emphasis on quality with special attention to raw ingredient selection and compliance for traceability.
We obtained ISO 9001:2015 certification in 2022 regarding the manufacturing of excipients for veterinary products.
In 2023, we achieved EXCiPACT® certification for the manufacturing of oil excipients dedicated to pharmaceutical use.